# Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

> **NCT01319695** · PHASE1,PHASE2 · COMPLETED · sponsor: **National and Kapodistrian University of Athens** · enrollment: 140 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** corifollitropin alfa
- **DRUG:** recombinant follicle stimulating hormone (FSH)

## Key facts

- **NCT ID:** NCT01319695
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2016-07
- **Final completion:** 2017-08
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01319695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01319695, "Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01319695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*